We are investigating whether combining imatinib with atezolizumab helps patients with advanced GIST who have not responded to other treatments. The study aims to assess survival rates and quality of life improvements.
Health conditions and diseases that the clinical trial is designed to study and treat.
Unresectable Gastrointestinal Stromal Tumor (GIST) refers to a type of tumor in the digestive tract that cannot be surgically removed. It is often associated with symptoms like abdominal pain, nausea, and gastrointestinal bleeding.
Metastatic Gastrointestinal Stromal Tumor occurs when GIST spreads from its original site to other parts of the body. Symptoms may include abdominal discomfort, swelling, and signs of metastasis in other organs.
Locally Advanced Gastrointestinal Stromal Tumor (GIST) is a stage of GIST where the tumor has grown but has not yet spread to distant sites. Symptoms can include abdominal pain, bloating, and changes in bowel habits.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.